Gleevec Combined With Camptosar Plus Paraplatin in Previously Untreated Extensive Stage Small Cell Lung Cancer
This study will evaluate combination chemotherapy for patients with extensive stage small cell lung cancer combined with the potentially useful growth inhibiting effects of Gleevec.
Lung Cancer
DRUG: Imatinib|DRUG: Irinotecan|DRUG: Carboplatin
Overall response rate|Response duration
Time to progression|Overall toxicity
Upon determination of eligibility, all patients will be receive:

* Irinotecan + Carboplatin + Imatinib